-
Mashup Score: 1European Commission approves Roche’s fixed-duration Columvi (glofitamab) for people with relapsed or refractory diffuse large B-cell lymphoma - 2 year(s) ago
Columvi is the first CD20xCD3 T-cell-engaging bispecific antibody available in Europe to treat the most common and aggressive form of lymphoma Approval…
Source: GlobeNewswire News RoomCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 2
LAUSANNE, Switzerland, July 11, 2023 (GLOBE NEWSWIRE) — ADC Therapeutics SA (NYSE: ADCT) today announced a voluntary pause in the enrollment of new…
Source: GlobeNewswire News RoomCategories: Latest Headlines, Partners & KOLsTweet
-
Mashup Score: 1
First Phase 3 Trial Evaluating Monotherapy with a Cardiac Myosin Inhibitor Compared to Monotherapy with a Beta Blocker in Adults with Symptomatic…
Source: GlobeNewswire News RoomCategories: Cardiologists, Latest HeadlinesTweet
-
Mashup Score: 4Aviv Clinics Spotlights New Hyperbaric Oxygen Therapy Study Sharing Its Effect on Myocardial Function in Post-COVID-19 Patients - 2 year(s) ago
Study finds unique hyperbaric oxygen therapy protocol is effective for patients suffering with cardiac dysfunction due to post-COVID-19…
Source: GlobeNewswire News RoomCategories: Latest Headlines, Partners & KOLsTweet
-
Mashup Score: 4Aviv Clinics Spotlights New Hyperbaric Oxygen Therapy Study Sharing Its Effect on Myocardial Function in Post-COVID-19 Patients - 2 year(s) ago
Study finds unique hyperbaric oxygen therapy protocol is effective for patients suffering with cardiac dysfunction due to post-COVID-19…
Source: GlobeNewswire News RoomCategories: Latest Headlines, Partners & KOLsTweet
-
Mashup Score: 4Aviv Clinics Spotlights New Hyperbaric Oxygen Therapy Study Sharing Its Effect on Myocardial Function in Post-COVID-19 Patients - 2 year(s) ago
Study finds unique hyperbaric oxygen therapy protocol is effective for patients suffering with cardiac dysfunction due to post-COVID-19…
Source: GlobeNewswire News RoomCategories: Latest Headlines, Partners & KOLsTweet
-
Mashup Score: 4Aviv Clinics Spotlights New Hyperbaric Oxygen Therapy Study Sharing Its Effect on Myocardial Function in Post-COVID-19 Patients - 2 year(s) ago
Study finds unique hyperbaric oxygen therapy protocol is effective for patients suffering with cardiac dysfunction due to post-COVID-19…
Source: GlobeNewswire News RoomCategories: Latest Headlines, Partners & KOLsTweet
-
Mashup Score: 4Aviv Clinics Spotlights New Hyperbaric Oxygen Therapy Study Sharing Its Effect on Myocardial Function in Post-COVID-19 Patients - 2 year(s) ago
Study finds unique hyperbaric oxygen therapy protocol is effective for patients suffering with cardiac dysfunction due to post-COVID-19…
Source: GlobeNewswire News RoomCategories: Latest Headlines, Partners & KOLsTweet
-
Mashup Score: 4Aviv Clinics Spotlights New Hyperbaric Oxygen Therapy Study Sharing Its Effect on Myocardial Function in Post-COVID-19 Patients - 2 year(s) ago
Study finds unique hyperbaric oxygen therapy protocol is effective for patients suffering with cardiac dysfunction due to post-COVID-19…
Source: GlobeNewswire News RoomCategories: Latest Headlines, Partners & KOLsTweet
-
Mashup Score: 4Aviv Clinics Spotlights New Hyperbaric Oxygen Therapy Study Sharing Its Effect on Myocardial Function in Post-COVID-19 Patients - 2 year(s) ago
Study finds unique hyperbaric oxygen therapy protocol is effective for patients suffering with cardiac dysfunction due to post-COVID-19…
Source: GlobeNewswire News RoomCategories: Latest Headlines, Partners & KOLsTweet
European Commission approves Roche’s fixed-duration Columvi (glofitamab) for people with relapsed or refractory diffuse large B-cell lymphoma #lymsm https://t.co/qX9jMt0Rwk